CommercialPrior AuthHigh impact
Artificial Lumbar Intervertebral Disc 7.01.63
Excellus BlueCross BlueShield·NY · Orthopedics, Neurosurgery, Pain Management +1 more·Bone & Joints (Orthopedic)
Effective date
Oct 15, 2025
We identified it
Jul 16, 2026
Summary
Excellus BlueCross BlueShield has implemented a new policy (effective October 15, 2025) establishing strict medical necessity criteria for artificial lumbar intervertebral disc arthroplasty. The policy requires patients to be aged 18-60, undergo 6+ months of conservative treatment without clinically meaningful improvement, meet specific imaging criteria (single-level L3-4, L4-5, or L5-S1 degeneration only), and absence of multiple contraindications including osteoporosis, spondylolisthesis >3mm, spinal stenosis, and autoimmune disorders. Prior authorization is now mandatory with extensive documentation requirements.
Action Required
By October 15, 2025: Billing and clinical teams must implement prior authorization requirements for all artificial lumbar intervertebral disc procedures. (1) Update billing system to mandate prior auth submission before claims processing for lumbar disc arthroplasty (regardless of CPT code used). (2) Providers must document in operative reports: patient age (18-60 confirmation), imaging findings (CT/MRI from independent radiologist confirming single-level moderate-severe DDD at L3-4, L4-5, or L5-S1 only, no degenerative disease above L3, no disease at multiple levels), absence of contraindications (osteoporosis T-score ≤-1.0, spondylolisthesis >3mm, stenosis, scoliosis >11°, facet ankylosis, disc height <3mm, mid-sagittal stenosis <8mm). (3) Obtain detailed documentation of 6+ consecutive months of failed conservative management including: prescription analgesics/NSAIDs/steroids/gabapentinoids AND provider-directed exercise program (PT/chiro/OMD/MD), with specific details on response to each modality and confirmation of less than clinically meaningful improvement. (4) Document mental/behavioral health screening showing absence of unmanaged major depressive disorder, chronic pain syndrome, secondary gain, opioid use disorder, or alcohol use disorder. (5) Verify FDA-approved device with FDA-approved indication per labeling. (6) Confirm no hybrid (simultaneous fusion) at adjacent levels planned. (7) Obtain flexion-extension X-rays and reconcile any discrepancies between surgeon and radiologist interpretations before submission. Claims submitted without complete prior authorization and documentation will be denied. Front desk staff must flag all lumbar disc arthroplasty referrals for pre-authorization routing. Billing team should establish checklist in system to verify all 9 criteria (A-I) from Section I before authorization submission.